AC Immune Analyst Ratings
AC Immune Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/07/2023 | 436.91% | HC Wainwright & Co. | → $16 | Reiterates | Buy → Buy |
| 06/28/2023 | 436.91% | HC Wainwright & Co. | → $16 | Reiterates | Buy → Buy |
| 05/01/2023 | 436.91% | HC Wainwright & Co. | → $16 | Reiterates | → Buy |
| 04/19/2023 | 436.91% | HC Wainwright & Co. | → $16 | Reiterates | → Buy |
| 03/17/2023 | 436.91% | HC Wainwright & Co. | → $16 | Reiterates | → Buy |
| 07/11/2022 | 235.57% | SVB Leerink | $15 → $10 | Maintains | Outperform |
| 12/20/2021 | 403.36% | SVB Leerink | $17 → $15 | Maintains | Outperform |
| 03/24/2021 | 436.91% | HC Wainwright & Co. | $11 → $16 | Maintains | Buy |
| 12/10/2019 | 269.13% | HC Wainwright & Co. | $8 → $11 | Reiterates | → Buy |
| 02/01/2019 | — | UBS | Downgrades | Buy → Neutral | |
| 11/13/2018 | 504.03% | Leerink Swann | → $18 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 08/07/2023 | 436.91% | HC Wainwright & Co. | → 16 美元 | 重申 | 购买 → 购买 |
| 06/28/2023 | 436.91% | HC Wainwright & Co. | → 16 美元 | 重申 | 购买 → 购买 |
| 05/01/2023 | 436.91% | HC Wainwright & Co. | → 16 美元 | 重申 | → 购买 |
| 04/19/2023 | 436.91% | HC Wainwright & Co. | → 16 美元 | 重申 | → 购买 |
| 03/17/2023 | 436.91% | HC Wainwright & Co. | → 16 美元 | 重申 | → 购买 |
| 2022 年 11 月 7 日 | 235.57% | SVB Leerink | 15 美元 → 10 美元 | 维护 | 跑赢大盘 |
| 2021 年 12 月 20 日 | 403.36% | SVB Leerink | 17 美元 → 15 美元 | 维护 | 跑赢大盘 |
| 2021 年 3 月 24 日 | 436.91% | HC Wainwright & Co. | 11 美元 → 16 美元 | 维护 | 购买 |
| 2019 年 10 月 12 日 | 269.13% | HC Wainwright & Co. | 8 美元 → 11 美元 | 重申 | → 购买 |
| 02/01/2019 | — | 瑞银（UBS） | 降级 | 买入 → 中性 | |
| 11/13/2018 | 504.03% | Leerink Swann | → 18 美元 | 启动覆盖开启 | → 跑赢大盘 |
What is the target price for AC Immune (ACIU)?
AC Immune (ACIU) 的目标价格是多少？
The latest price target for AC Immune (NASDAQ: ACIU) was reported by HC Wainwright & Co. on August 7, 2023. The analyst firm set a price target for $16.00 expecting ACIU to rise to within 12 months (a possible 436.91% upside). 5 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2023年8月7日公布了AC Immune（纳斯达克股票代码：ACIU）的最新目标股价。这家分析公司将目标股价定为16.00美元，预计ACIU将在12个月内升至16.00美元（可能上涨436.91％）。去年有5家分析公司公布了评级。
What is the most recent analyst rating for AC Immune (ACIU)?
分析师对AC Immune (ACIU) 的最新评级是多少？
The latest analyst rating for AC Immune (NASDAQ: ACIU) was provided by HC Wainwright & Co., and AC Immune reiterated their buy rating.
AC Immune（纳斯达克股票代码：ACIU）的最新分析师评级由HC Wainwright & Co. 提供，AC Immune 重申了他们的买入评级。
When is the next analyst rating going to be posted or updated for AC Immune (ACIU)?
AC Immune (ACIU) 的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AC Immune, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AC Immune was filed on August 7, 2023 so you should expect the next rating to be made available sometime around August 7, 2024.
分析师在进行了广泛的研究，包括浏览公开财务报表、与AC Immune的高管和客户交谈以及听取财报电话会议后得出股票评级。大多数分析师每三个月进行一次评级，因此每家公司每年应该获得4个评级。AC Immune 的最新评级是在2023年8月7日提交的，因此你应该预计下一个评级将在2024年8月7日左右公布。
Is the Analyst Rating AC Immune (ACIU) correct?
分析师对 AC 免疫力 (ACIU) 的评级是否正确？
While ratings are subjective and will change, the latest AC Immune (ACIU) rating was a reiterated with a price target of $0.00 to $16.00. The current price AC Immune (ACIU) is trading at is $2.98, which is within the analyst's predicted range.
虽然评级是主观的，会发生变化，但最新的AC Immune（ACIU）评级得到了重申，目标股价为0.00美元至16.00美元。AC Immune（ACIU）目前的交易价格为2.98美元，在分析师的预测区间内。